ReviewNucleic acids research2026
Transforming subcellular spatial transcriptomics: deep learning models for cell segmentation.
Review in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Subcellular spatial transcriptomics (SSTs) is transforming biology by revealing where individual RNA molecules are located within intact tissues, providing unprecedented insight into how cells function and interact. Achieving this promise depends on accurately identifying the boundaries of individual cells, making cell segmentation one of the field's central computational challenges. A core methodological issue is how best to ensure correct and biologically accurate assignment of transcripts to cells using cell segmentation algorithms. Recent advances in deep learning models have been instrumental in developing tools to enable more accurate transcript-to-cell maapping across a wider range of tissues and resolutions. Here, we review key features of emerging deep learning-based cell segmentation strategies, including fully convolutional neural networks, transformer-based models, and foundation models, highlighting their architectural innovations, performance characteristics, and practical limitations. We conclude that transformer-based and foundation model-based models have better generalizability and require minimal retraining, but their adoption is limited by larger data requirements and higher computational cost. We predict a larger adoption of these more flexible and robust methods as deep learning architectures become more scalable and improved hardware accessibility permits further advancements of quantitative, high-resolution tissue analysis. We propose that the convergence of biology and artificial intelligence (AI) and the continued innovation in deep learning-based cell segmentation will accelerate method development, standardization, and deployment in both basic biological research and clinical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.